| INTRODUCTION
Following Semm's description of the first laparoscopic appendectomy (called at the time an endoscopic appendectomy), 1 minimally invasive surgery (MIS) has achieved rapid adoption in general surgery procedures ranging in complexity from laparoscopic appendectomy and cholecystectomy 2 to complex hiatal hernia repairs. [3] [4] [5] More recently, many surgeons have applied MIS approaches to oncologic operations.
Though the initial reports of laparoscopic colectomy for colon cancer appropriately cautioned slow adoption of this technique, 6 subsequent reports have demonstrated that laparoscopic approaches are oncologically equivalent to the corresponding open operation in appropriately selected patients. [7] [8] [9] [10] [11] [12] [13] As experience with MIS has increased and surgeons have become comfortable with application for surgical oncology cases, rates of MIS resections have increased. 14, 15 In addition to compelling data on oncologic equivalency, 16 MIS approaches have demonstrated lower rates of certain post-operative complications and shorter length of stay. [17] [18] [19] [20] The adoption of laparoscopic approaches has been gradual due to technical, time-related, and ergonomic challenges for the operative surgeon. 21 Robotic surgery offers a potential bridge for these downsides, and may shorten the learning curve for both benign and malignant surgical procedures. 22 However, robotic approaches have been challenged because of the perceived expense of the robotic platform.
23-26
We perform a high volume of complex surgical oncology procedures and, over time, have increased the percentage of resections that occur minimally invasively. 17, 18 The aim of this report is to characterize our institutional experience with the adoption of MIS approaches to complex intra-abdominal malignancies. 27 and classify the resection extent as either a right hemicolectomy, left hemicolectomy, low anterior resection, abdominoperineal resection, or a total colectomy. For all rectal resections it is our practice to perform a tumor-specific TME, and for all intraabdominal colectomies we ligate the appropriate artery and vein at their root. We report R0 resection rates for all gastrectomies, hepatic resections, distal pancreatectomies for pancreatic adenocarcinoma, and all low anterior resections.
| MATERIALS AND METHODS
All complications are prospectively graded on our modification of the Clavien-Dindo classification. 28 
| Indication for surgical resection
As with extent of resection, organ-specific indications for surgical resection showed significant variation by surgical approach (Table 1) .
Patients with early-stage gastric cancer were more likely to undergo Procedure-specific trends (Fig. 2) are similar, but differences within the resection types highlight the most important aspect of MIS approaches to any surgical procedure: laparoscopic and robotic approaches are a tool in the surgeon's armamentarium, to be used for appropriately selected cases in which oncologic equivalency is the first and foremost goal.
Ability to achieve complete tumor resection with negative margins, complete lymphadenectomy, restoration of intestinal continuity, and, most importantly, patient selection, remain, regardless of which approach a surgeon chooses for their patient's resection.
Despite the high volume of procedures performed at our institution, Table 1) . The evolution of our use of MIS techniques and the associated patient selection is demonstrated by BMIs in patients early on in our MIS experience (Fig. 3 ). As familiarity with the MIS techniques increased, this selection factor was mitigated, and the BMI differences narrowed and then disappeared ( Figs. 1 and 2). We have also narrowed, but not eliminated, the differences between procedure-specific resection extent of patients undergoing open and MIS resections. More extensive gastric and hepatic Hope's experience with robotic surgery. 29 They found, as we did, that their institution was able to transition from open approaches to robotic approaches with no change in morbidity and mortality. Nationally, however, the role for robotic surgery is still being actively debated. 15 Nevertheless, our institutional experience demonstrates a rapidly growing and evolving interest in robotic approaches for well-selected oncologic resections.
We have previously reviewed our institutional experience with MIS resections for gastrectomies, 11, 17 hepatectomies, 13 and distal pancreatectomies 9,18 as well as a review of our early adoption of laparoscopy. 10 Each of these reports separately describes the organspecific factors important in selecting a patient for a specific MIS resection. Broadly, both laparoscopic and robotic surgical approaches have been shown as oncologically equivalent to their open counterparts. However, the technical challenges inherent to these approaches highlight the need for individual surgeons to carefully evaluate their surgical outcomes and ensure that, especially early on in one's MIS experience, the priorities of patient outcomes, safety, and oncologic equivalency remain, regardless of surgical approach. In this institutional report, we did not focus on rates of conversion from MIS to open approaches. While these rates are important, they reflect procedurespecific patient selection and technical considerations that are best discussed in disease and procedure-specific reports. 
